Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Operating Expenses | 15,302 | 11,348 | 4,037 | 1,095 | 3,130 |
| Operating Income | -15,302 | -11,348 | -4,037 | -1,095 | -3,130 |
| Interest Expense | 53 | 60 | 38 | N/A | 14 |
| Other Income | 4,744 | 311 | 47 | 28 | 3,144 |
| Pre-tax Income | -10,611 | -11,097 | -4,028 | -1,067 | N/A |
| Income Tax | 7 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -10,617 | -11,097 | -4,028 | -1,067 | -3,109 |
| Net Income | $-10,617 | $-11,097 | $-4,028 | $-1,067 | $-3,109 |
| EPS Basic Total Ops | -1.60 | -2.64 | -3.10 | -18.09 | -5.88 |
| EPS Basic Continuous Ops | -1.60 | -2.64 | -3.10 | -18.09 | -5.88 |
| EPS Diluted Total Ops | -1.60 | -2.64 | -3.10 | -18.09 | -5.88 |
| EPS Diluted Continuous Ops | -1.60 | -2.64 | -3.10 | -18.09 | -5.88 |
| EBITDA(a) | $-10,228 | $-10,470 | $-3,381 | $-1,089 | $-2,880 |